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related muscle cramps with continued use if successful.
Further study with a larger randomized clinical trial is war-
ranted.
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Prevalence and Correlates of Indoor Tanning
in Nonsalon Locations Among aNational Sample
of YoungWomen
Indoor tanning is a public health threat,1 and the SurgeonGen-
eralhascalledfor its reductioninadolescentsandyoungadults.2
Research on indoor tanning has not distinguished between
tanning-only salonsvsotherbusinessesandprivate residences
thatprovide tanning (ie,nonsalon tanning).Forexample, gyms
oftenofferfreetanning,whichmayleadtoriskiertanninghabits.3
Betterunderstandingofnonsalontanningcouldhavepolicy,pre-
vention, andclinical implications.Our studyaddresses this lit-
eraturegapbyexamining theprevalenceandcorrelatesofnon-
salon tanning in a nationally representative sample of young
women,who have the highest rates of indoor tanning use.
Methods | Rutgers Institutional Review Board approved the
study and all participants signed an online consent form pre-
sented prior to the study. A nationally representative sample
of 823 women aged 18 to 25 years (mean age, 22.7 years; 463
[56.3%] non-Hispanic white, 118 [14.3%] non-Hispanic black,
174 [21.1%] Hispanic, and 68 [8.3%] non-Hispanic other) was
recruited through GfK Knowledge Networks, a research sur-
vey firm that uses address-based sampling methods to re-
cruit a probability-based online panel of 55 000 adults from
which this sample was drawn. Participants were paid $5 for
completing the survey.Measures includeddemographics, life-
time indoor tanning use (ever used indoor tanning), current
indoor tanning frequency (past 12 months), and indoor tan-
ning location (tanning-only salonor locationother than a tan-
ning-only salon). Participantswho indicated they tanned at a
nonsalon location identified the location as a gym or health
club, beauty shop, private home, apartment, or other loca-
tion. Participants who currently use indoor tanning com-
pleted measures of indoor tanning patterns4 (event or year-
roundpattern)and indicatedwhether theyused indoor tanning
to improve their mood and how difficult it would be to stop
using indoor tanning (proxymeasureof tanningdependence5).
Historyof depression andanxietywere alsomeasured.Analy-
sis of categorical variables used χ2 difference tests and con-
tinuousoutcomesusedbivariate general linearmodels inSPSS
Complex Samples, version 21 (SPSS Inc).
Results | Forty-one percent (unweighted n = 123) of partici-
pants who ever used indoor tanning and 24.6% (n = 34) of
current indoor tanning users reported nonsalon tanning
(Table 1). Participants who had ever used indoor tanning
most commonly used indoor tanning at gyms (64 [18.9%]),
beauty shops (39 [13.8%]), and private homes (40 [13.2%]).
Participants who were currently using nonsalon indoor tan-
ning most often used indoor tanning at gyms (20 [9.8%]),
private homes (13 [7.7%]), and apartment complexes (10
[7.5%]). The number of lifetime indoor tanning sessions was
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more than 2 times greater for those who had ever used a
nonsalon location (75.7) than those who had not (35.0)
(P = .02) (Table 2). In participants who were currently using
nonsalon indoor tanning, tanning to improve mood (P = .06)
and year-round tanning (P < .001) were more common rela-
tive to participants who used tanning-only salons. Partici-
pants who were currently using nonsalon indoor tanning
reported a history of depression almost 3 times higher
(P = .047) and difficulty stopping indoor tanning (P = .01)
than those exclusively using tanning-only salons.
Discussion | Our findings indicate nonsalon indoor tanning is
commonwith current indoor tanningusers (24.6%) and those
whohaveeverused indoor tanning (41.0%).Gymsare themost
typical location of nonsalon indoor tanning. Nonsalon in-
door tanning users report more depression, tanning depen-
dence, tanning to improvemood, and lifetime tanning. They
are also more likely to use indoor tanning year round. Some
indoor tanning users might seek out gyms to circumvent the
federal tanning excise tax, which gyms are not required to
collect.6Nonsalon tanning locations also seemtoattractmore
high-risk tanners (ie, those who are depressed or have a de-
pendence on tanning). Despite this evidence, we know little
about the supervision, regulation, or maintenance of nonsa-
lon tanning locations. Future research needs to assess tan-
ning location along with other indoor tanning variables. Re-
search should examine the reasons nonsalon locations are
popularwith high-risk tanners, aswell as factors thatmay ex-
plain theuseofnonsalon locations, suchas convenience, cost,
physical activity (eg, gym tanning), and living arrangements
(eg, apartment tanning). Private home tanning, which has no
regulationsor oversight, shouldbe carefully studied.Weneed
tobetter characterize the supervision,maintenance, and regu-
lationofnonsalon locations to informclinical, prevention, and
policy decisions.
Limitationsof this study include its focusonadultwomen
only, cross-sectional data, and the inability to assess nonsa-
lon categories independently owing to small sample size.
Physician counseling to reduce indoor tanning is a recom-
mendedpreventivehealthservice.Physiciansshouldassesspa-
tients’ tanning locations since nonsalon tanningmay indicate
more risky behavior.
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Table 1. Prevalence of Nonsalon Indoor Tanning Among Young Adult
WomenWho Reported Indoor Tanning
Characteristic
Indoor Tanning History, Unweighted No.
(Weighted %)
Lifetime Usersa Used in the Past 12 mob
Prevalence of nonsalon
indoor tanning
123 (41.0) 34 (24.6)
Location of nonsalon tanning
Gym or health club 64 (18.9) 20 (9.8)
Beauty shop 39 (13.8) 8 (4.0)
Private home 40 (13.2) 13 (7.7)
Apartment complex 19 (5.7) 10 (7.5)
Other 16 (6.4) 5 (3.5)
a Among participants who reported ever using indoor tanning (estimate of
weighted n = 217.5; 26.7% of the weighted sample).
bAmong participants who reported any indoor tanning in the past 12 months
(estimate of weighted n = 107.9; 13.2% of the weighted sample).
Table 2. Bivariate Analyses of the Correlates of Nonsalon Indoor Tanning Among Young AdultWomenWhoUse Indoor Tanning
Characteristic
Mean Weighted (95% CI)
Ever Used Indoor Tanninga Currently Use Indoor Tanningb
Salon-only Nonsalon P Value Salon-only Nonsalon P Valuec
Lifetime indoor tanning sessions, No. 35.0 (26.9-43.1) 75.7 (41.6-109.8) .02 76.4 (38.9-113.9) 82.8 (45.5-120.2) .81
Past 12-mo indoor tanning sessions, No. 7.0 (4.0-9.9) 11.3 (4.1-18.5) .81 15.2 (10.6-19.8) 25.6 (3.0-47.6) .38
Nonmetropolitan area, % 15.1 (9.9-22.6) 25.4 (17.0-36.2) .07 21.7 (13.3-33.4) 36.2 (18.3-58.9) .20
Ever experienced depression, % 13.7 (8.3-21.9) 17.3 (10.9-26.4) .49 11.6 (5.1-24.2) 31.6 (15.3-54.1) .047
Ever experienced anxiety, % 16.8 (10.2-26.5) 17.0 (10.9-25.5) .97 18.1 (9.2-32.4) 18.2 (6.5-41.5) .99
Mean difficulty to stop tanningd 3.3 (2.5-4.2) 5.28 (4.1-6.5) .01
% Event tanning pattern, %d 69.0 (56.3-79.4) 36.4 (19.5-57.5) .007
% Mood tanning pattern, %d 15.4 (7.8-28.1) 37.6 (18.1-62.1) .06
% Year-round tanning pattern, %d 7.5 (3.3-16.1) 35.4 (17.8-58.1) <.001
a Among participants who reported ever using indoor tanning (estimate of
weighted n = 217.5; 26.7% of the weighted sample).
bAmong participants who reported any indoor tanning in the past 12 months
(estimate of weighted n = 107.9; 13.2% of the weighted sample).
c P values represent results of overall significance tests based on the adjusted F
statistic provided by SPSS with analyses of weighted data.
dVariables assessed only for participants who reported at least 1 indoor tanning
session in the past 12 months.
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OBSERVATION
Erythema in Skin Adjacent to Area of Long-term
Brimonidine Treatment for Rosacea:
ANovel Adverse Reaction
We describe a case of compensatory vasodilation in the vas-
culature surrounding the siteof long-termbrimonidineuse for
the treatment of rosacea.
Report of a Case |A57-year-oldwomanwithamedicalhistoryof
rosacea, anxiety, hyperlipidemia, andhypertension presented
withpersistent,patchyerythemaonthe lateral faceandneckof
severalweeks’duration.Sevenmonthsbeforepresentation,she
hadbeenprescribedbrimonidine,0.33%, topical gel forpersis-
tent facial erythemasecondary to rosacea. She reportedappro-
priateuseofthemedication,applyingtheprescribedamountonly
to affected areas on her central face. Physical examination re-
vealedmarked bright erythemadiffusely covering areas of the
lateral cheeks, neck, andupper chest (Figure, A). Interestingly,
therewasclearsparingof thesitesofbrimonidineapplicationon
the central face.
Reviewof systems revealed only that the eruptionwas as-
sociatedwithmildburning.Prior topresenting toourclinic, she
saw several other dermatologists. Over the course of these vis-
its,several laboratorystudieswereordered, includingacomplete
blood cell countwith differential, a completemetabolic panel,
a lipidpanel,andmeasuresofC1, total complement,antinuclear
antibody(ANA),andtryptase,allofwhichyieldednormalresults.
A cutaneous punch biopsy of the left neckwas performed and
revealednonspecific findingsofphotodamagedskinwithtelan-
giectasiasandscantperivascular lymphocytic inflammationwith
Figure. Clinical Images Before and After Brimonidine Treatment Cessation
After 7 months of brimonidine therapyA One week after brimonidine treatment cessationB
A, Patient at initial clinic visit after 7
months of brimonidine treatment,
showing compensatory
vasodilatation and flushing in
untreated areas of right lateral cheek,
neck, and chest. B, Patient 1 week
after cessation of brimonidine
treatment, showingmarked
improvement in compensatory
vasodilatation and flushing.
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